Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

GTBP holding history

GT Biopharma, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GTBP overviewAll 13F holders of GTBPFull Q2 2026 holdings

Shares (Q2 2026)
2
Value
$1
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GTBP by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262$1<0.1%−45,968−100.0%ReducedHolders
Q1 202645,970$18.8K<0.1%+45,969+4,596,900.0%AddedHolders
Q4 20251$1<0.1%−2,625−100.0%ReducedHolders
Q3 20252,626$1.54K<0.1%−3,184−54.8%ReducedHolders
Q2 20255,810$20.8K<0.1%+3,251+127.0%AddedHolders
Q1 20252,559$5.50K<0.1%−2,437−48.8%ReducedHolders
Q4 20244,996$15.2K<0.1%+1,093+28.0%AddedHolders
Q3 20243,903$9.01K<0.1%−5,078−56.5%ReducedHolders
Q2 20248,981$25.4K<0.1%+7,958+777.9%AddedHolders
Q1 20241,023$4.53K<0.1%+536+110.1%AddedConverted for a 1-for-30 splitHolders
Q4 202314,605$3.72K<0.1%+5,855+66.9%AddedHolders
Q3 20238,750$2.11K<0.1%+5,717+188.5%AddedHolders
Q2 20233,033$946<0.1%−4,760−61.1%ReducedHolders
Q1 20237,793$4.29K<0.1%+4,270+121.2%AddedHolders
Q4 20223,523$3.13K<0.1%+353+11.1%AddedHolders
Q3 20223,170$5.00K<0.1%+54+1.7%AddedHolders
Q2 20223,116$9.00K<0.1%−1,285−29.2%ReducedHolders
Q1 20224,401$13.0K<0.1%−7,043−61.5%ReducedHolders
Q4 202111,444$34.0K<0.1%+6,686+140.5%AddedHolders
Q3 20214,758$32.0K<0.1%+1,655+53.3%AddedHolders
Q2 20213,103$48.0K<0.1%−815−20.8%ReducedHolders
Q1 20213,918$27.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.